Vanadium: A panacea for resistance to oncolytic immunotherapy? Journal Article
| Author: | Zamarin, D. |
| Article Title: | Vanadium: A panacea for resistance to oncolytic immunotherapy? |
| Keywords: | nonhuman; t lymphocyte; stat1 protein; melanoma; dendritic cell; transcription initiation; cancer resistance; diabetes mellitus; oncolytic virus; oncolytic virotherapy; short survey; virus replication; rna virus; protein tyrosine phosphatase shp 1; phosphoprotein phosphatase; intracellular signaling; tumor cell destruction; interferon production; vanadic acid; talimogene laherparepvec; human; vanadium derivative; vesiculovirus |
| Journal Title: | Molecular Therapy |
| Volume: | 26 |
| Issue: | 1 |
| ISSN: | 1525-0016 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2018-01-03 |
| Start Page: | 9 |
| End Page: | 12 |
| Language: | English |
| DOI: | 10.1016/j.ymthe.2017.12.006 |
| PROVIDER: | scopus |
| PMCID: | PMC5763147 |
| PUBMED: | 29249394 |
| DOI/URL: | |
| Notes: | Short Survey -- Export Date: 1 February 2018 -- Source: Scopus |
